Benzonatate (BZN)
Benzonatate is a non-narcotic oral cough suppressant, or antitussive. Its formal name is 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl para-butylaminobenzoate.Benzonatate is a butylamine, chemically related to other ester local anesthetics such as procaine and tetracaine. Benzonatate is thought to act as a local anesthetic, decreasing the sensitivity of stretch receptors in the lower airway and lung, thereby reducing the drive to cough after taking a deep breath. An antitussive, benzonatate is employed to reduce coughing in various respiratory conditions such as bronchitis, emphysema, influenza, and pneumonia. It should never be used to suppress a productive cough producing mucus that can be spit out, or in place of treatment of the actual cause of cough, such as asthma treatment. It has been used in small doses as a topical anesthetic for mouth or pharyngeal pain.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Benzonatate (BZN) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Benzonatate (BZN) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Benzonatate (BZN) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Benzonatate (BZN) CLIA Kit Customized Service Offer
n/a ELISA Kit for Benzonatate (BZN) ELISA Kit Customized Service Offer